Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Trump Criticizes FDA For 'Slow' Approvals In Speech To Congress

01 Mar 2017

• By Sue Darcey

Trump_Donald_160716_1200x675

Related Content

Trump's Two-For-One Reg Order Needs Agency Interpretation, Medtech Reg Experts Say

31 Jan 2017

AdvaMed Pushes For Trump To Address Device Tax In Joint-Session Address

27 Feb 2017

GOP ACA-Replacement Draft: Device Tax Would Go Away; States Left To Decide Plan Coverage

28 Feb 2017

Related Companies

Novazyme Pharmaceuticals Inc.

Sanofi

Sanofi Genzyme

Amicus Therapeutics, Inc.

Additional Topics

United States Policy Regulation Reimbursement Medical Device

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.